CLARIVATE PLC
Close on Oct 19, 2026
- Market cap
- $1.13B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Oct 28, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 29, 2026 | Before market open | $587.30M | $-0.42 | $0.19 |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 29, 2026 | Before market open | $585.50M | $-0.06 | $0.18 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 24, 2026 | Before market open | $617.00M | $0.00 | $0.20 |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 29, 2025 | Before market open | $623.10M | $-0.04 | $0.18 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 30, 2025 | Before market open | $621.40M | $-0.11 | $0.18 |
| Q1 FY2025 Ended Mar 31, 2025 | Apr 29, 2025 | Before market open | $593.70M | $-0.15 | $0.14 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 19, 2025 | Before market open | $663.00M | $-0.27 | $0.21 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | Before market open | $622.20M | $-0.09 | $0.19 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | $650.30M | $-0.46 | $0.20 |
| Q1 FY2024 Ended Mar 31, 2024 | May 8, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Jul 29, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Capital expendituresGAAP | Year Ending December 31, 2026 | -$245.00M | Raised |
| Adjusted EBITDAnon-GAAP | Full Year 2026 Outlook | $980.00M to $1.04M | Lowered |
| Adjusted Diluted EPSnon-GAAP | Full Year 2026 Outlook | $0.70 to $0.80 | Maintained |
| Net income (loss) per shareGAAP | Year Ending December 31, 2026 | $-0.64 to $-0.54 | Lowered |
| Free Cash Flownon-GAAP | Full Year 2026 Outlook | $365.00M to $435.00M | Maintained |
| ACV Organic Growthnon-GAAP | Full Year 2026 Outlook | 2% to 3% growth | New |
| Net income (loss)GAAP | Year Ending December 31, 2026 | -$418.00M to -$353.00M | Lowered |
| Net cash provided by operating activitiesGAAP | Year Ending December 31, 2026 | $610.00M to $680.00M | Raised |
| Adjusted EBITDA Marginnon-GAAP | Full Year 2026 Outlook | 42% to 43.5% | Maintained |
| Recurring Organic Revenue Growthnon-GAAP | Full Year 2026 Outlook | 0.75% to 2.25% growth | Lowered |
| RevenuesGAAP | Year Ending December 31, 2026 | $1.94B to $2.04B | New |
| Revenues, Including Discontinued Operationsnon-GAAP | Full Year 2026 Outlook | $2.30B to $2.42B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Clarivate filed with the SEC
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Acquisition or disposition completed · Executive or director change · Other events · EX-99.1 to Form 8-K
Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Other events · EX-99.1 to Form 8-K
Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Other events · EX-99.1 to Form 8-K
Clarivate Commences Offer to Purchase for Cash
Other events · EX-99.1 to Form 8-K
Clarivate Appoints Michael Easton as Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Clarivate Reports Second Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q2 2026 Earnings Call July 29, 2026
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
Regulation FD disclosure · EX-99.1 to Form 8-K
LS&H Divestiture Investor Call July 6, 2026
Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Announces Simon Webster as President of Intellectual Property Segment
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Clarivate Reports First Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q1 2026 Earnings Call April 29, 2026
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Reports Fourth Quarter and Full Year 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q4 2025 Earnings Call February 24, 2026
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities
Agreement terminated · Other events · EX-99.1 to Form 8-K
Clarivate Reports Third Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q3 2025 Earnings Call October 29, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
London, U.K. — July 30,
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Clarivate Reports Second Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q2 2025 Earnings Call July 30, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Completes Refinancing of Majority
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Clarivate Reports First Quarter 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q1 2025 Earnings Call Apr 29, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Reports Fourth Quarter and Full Year 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q4 2024 Earnings Call February 19, 2025
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Announces New $500 Million Share Repurchase
Regulation FD disclosure · EX-99.1 to Form 8-K
Clarivate Reports Third Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q3 2024 Earnings Call November 6, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Reports Second Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q2 2024 Earnings Call August 6, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Reports First Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q1 2024 Earnings Call May 8, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Reports Fourth Quarter and Full Year 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q4 2023 Earnings Call February 27, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Completes Refinancing of Term Loan and Revolver Extension
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Commencement of Term Loan Refinancing Transaction
Results of operations · EX-99.1 to Form 8-K
Clarivate Reports Third Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Q3 2023 Earnings Call November 7, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Clarivate Announces Termination of Tax Benefits
Other events · EX-99.1 to Form 8-K
Clarivate Reports Second Quarter 2023 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K